Three US Fingolimod Approvals Raise Legal Stakes

Approvals for Biocon, HEC and Sun Pharma

 
• By Aidan Fry
  
Bollards
Three fingolimod generics have been approved in the US, but legal issues may block their path to market • Source: Shutterstock

More from Products

More from Generics Bulletin